- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 28, 2026 | 27.88M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 28.49M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 28.04M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $1.83M |
| Capex | Q1 2026 · Mar 31, 2025 | $536K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $15.99M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $7.12M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $222.15M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $123.51M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $528.42M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $517.1M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $468.98M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $457.94M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $4.81B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $4.89B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $5.34B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $5.41B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.58 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.31 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.59 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.31 |
| Net Income | Q1 2026 · Mar 31, 2026 | $17.41M |
| Net Income | Q1 2026 · Mar 31, 2025 | $9.63M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $621K |